LifeScience Biologics
China’s Hiteck Biological Pharma Licenses Next-Generation Eye Therapy to Visara for Global Development
Wuhan Hiteck Biological Pharma Co., Ltd. announced that it has entered into an exclusive license agreement (the "License Agreement") with Visara, Inc...
October 14, 2026 | News
Insilico Medicine Nominates AI-Designed VAV1 Molecular Glue Degrader for Autoimmune Diseases
VAV1 (Vav guanine nucleotide exchange factor 1) plays a key role in immune cell signaling pathways, holding immense potential in autoimmune disease interve...
October 14, 2026 | News
CellCarta Partners with Waters Corporation to Advance Companion Diagnostics and Next-Generation Flow Cytometry
CellCarta, a leading global CRO laboratory to the biopharmaceutical industry, announced a strategic partnership with Waters Corporation, a global lea...
October 14, 2026 | News
LOTTE Biologics and Alvotech Forge Long-Term Partnership to Expand Global Biosimilar Manufacturing Capacity
Collaboration covers multiple biosimilar products to be manufactured at LOTTE Biologics' Syracuse facility in New York Strategic long-term partnershi...
October 13, 2026 | News
SOPHiA GENETICS, Myriad Genetics and AstraZeneca Collaborate to Advance Precision Oncology in Prostate Cancer
SOPHiA GENETICS (NASDAQ: SOPH) and Myriad Genetics, Inc., (NASDAQ: MYGN) announce a collaboration to advance new prostate cancer-specific genomi...
October 13, 2026 | News
Rockwell Automation Joins Digital CMC Consortium to Accelerate Drug Development and Pharmaceutical Manufacturing
Rockwell Automation, Inc. (NYSE: ROK), the world's largest company dedicated to industrial automation and digital transformation, announced it is a fo...
October 13, 2026 | News
12 APAC-Originated Programmes to Watch at ESMO 2026
When the ESMO Congress 2026 opens at IFEMA Madrid on Friday 23 October, the region that most European oncologists still think of as a fast follower will ho...
October 13, 2026 | News
Helfie AI Partners With Kenya’s Homa Bay County to Pilot AI-Powered Health Screening for 100,000 People
Helfie AI ("Helfie"), an AI-powered preventive network transforming global healthcare, announced it has signed a Memorandum of Understanding (MOU) wi...
October 12, 2026 | News
Innovent’s SYCUME Meets Primary Endpoint in Phase III Trial for Inactive Thyroid Eye Disease in China
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality me...
October 12, 2026 | News
Akeso Initiates Phase III Trial of Cadonilimab for Resectable MSI-H/dMMR Colon Cancer
Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that the first patient has been dosed in a Phase III clinical study (COMPASSION-40/AK104-313) ev...
October 12, 2026 | News
Semaglutide Generics, Six Months In: Every Launch in India, Every Price, and Where China Stands
AT A GLANCE 12 generic makers with a public launch in India, selling 20 brands between them Rs 1,290 lowest stated monthly price, for vials...
October 09, 2026 | Analysis
Quanterix and Innovita Secure China Regulatory Approvals for SIMOA-Based Alzheimer's Disease Biomarker Tests
Quanterix Corporation (NASDAQ: QTRX), a global leader in precision biomarker science, and Innovita Biological Technology Co., Ltd. (SSE: 688253.SH), a lead...
October 09, 2026 | News
Resonant Clinical Solutions and Haier Biomedical Launch Eco-Friendly Centrifuge for Clinical Trials
Resonant Clinical Solutions – a global clinical solutions partner serving life sciences organizations across the clinical supply chain and sample lif...
October 09, 2026 | News
Suzhou Ribo Life Science Submits Phase I Clinical Trial Application in EU for siRNA Obesity Therapy RBD3133
Suzhou Ribo Life Science (06938.HK) and its subsidiary Ribocure Pharmaceuticals AB (collectively referred to as "Ribo") announced the successful submission...
October 09, 2026 | News
Most Read
- Can APAC Biomanufacturing Decarbonise Without Pricing Itself Out?
- The Algorithm on the GMP Floor: AI Promises a Smarter Plant. Regulators Demand the Audit Trail.
- APAC's Peptide-Capacity Gamble
- After the Rush: APAC's mRNA and Vaccine Capacity Hangover
- The Biosimilar Race: Factory to the World — or Stuck in the Copycat Economy?
- The Vein-to-Vein Problem: Can APAC's Cold Chain Carry Advanced Therapies?
- Vectors, Plasmids and the CGT Trap: APAC's Cell and Gene Therapy Ambitions Face an Upstream Bottleneck
- Can APAC Build Radioligand Therapy Before the Atoms Decay?
- The Great Biopharma Reset: 50 Developments That Changed Everything in H1 2026
- Beyond the Trial: Can Real-World Evidence Earn Regulatory Trust in APAC?
- Beyond the Obvious Giant: Where APAC's Clinical Trials Go Next
- The Frontier That Won’t Quite Arrive
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
